BOSTON and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CNTA), a clinical stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are ...

波士顿 - 市值22.8亿美元的临床阶段制药公司Centessa Pharmaceuticals plc (NASDAQ:CNTA)宣布任命Stephen Kanes医学博士为新任首席医疗官。Kanes博士是一位在神经科学、临床精神病学和药物开发方面拥有30多年经验的神经精神病学专家。他加入Centessa之际，公司正在推进其催眠素受体2 (OX2R)激动剂组合的开发，预计今年将达成多个临床里程碑 ...

Fintel reports that on January 7, 2025, TD Cowen initiated coverage of Centessa Pharmaceuticals plc - Depositary Receipt () ...

Centessa Pharmaceuticals Plc (CNTA) said on Wednesday that it has appointed Stephen Kanes as its Chief Medical Officer. Kanes is a ...

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines ...

FORM 8.3 The naming of nominee or vehicle companies is insufficient. For a trust, the trustee (s), settlor and beneficiaries must be named. For an opening position disclosure, state the latest ...

Biopharmaceutical company developing drugs for neurological disorders.

The Roman Empire lowered IQ levels across Europe according to a new study, due to the vast quantities of lead pollution churned out by the booming metals industry. Researchers have said the massive ...